fertility TCART Toronto Centre for Advanced Reproductive Technology
    site map contact us TCART home page
fertility
   
 
>> view stats >> view staff vision of tomorrow at TCART
icsi at TCART  
     
Fertility services in Toronto fertility services and programs
 

Intracytoplasmic Sperm Injection (Is It Safe?)

Robert F. Casper
Professor and Head
Division of Reproductive Sciences
The University of Toronto


Recently, concerns have been raised that there may be risks to the offspring born from ICSI, as a result of the procedure itself. This summary is a review of the recent literature, which will serve to address these concerns and put the potential risks into perspective. The bottom line is that ICSI appears to be remarkably safe, but further follow up of babies born from this procedure is required. There are several reasons for concern regarding the safety of ICSI. First of all, the natural selection process by which sperm normally fertilizes the egg is bypassed and a single sperm is selected for mechanical injection into the oocyte. In addition, it is known that chromosomal abnormalities in infertile males are more common and these abnormalities maybe transmitted to the offspring. Finally, insertion of sperm by injection into the cytoplasm could damage the egg with resulting problems in cell division later on.

 

Genetic Evaluation of Sub fertile Males

Genetic abnormalities may cause low sperm counts and male infertility. These genetic abnormalities are potentially transmissible to a baby born through assisted reproductive procedures. The three most common known genetic factors related to male infertility are:

  1. Cystic fibrosis gene mutations leading to congenital absence of the vas deferens (the tube that carries sperm from the testicle to the penis).
  2. Deletions of one or more genes present on the Y chromosome, which are necessary for normal sperm development.
  3. Chromosomal abnormalities, most frequently extra X or Y-chromosomes, which may be associated with severely reduced sperm counts, or no sperm at all, in the semen.

A recent paper from Holland (Tuerlings et al, 1998) reported results of chromosomal analysis on almost 1800 men with severe low sperm counts or no sperm in the ejaculate. Seventy-two of the men or 4% had a chromosomal abnormality, most of which were numerical sex chromosomal (X or Y chromosomes) abnormalities. It is very likely, in view of the large number of men studied, that the figure of 4% is an accurate prevalence of chromosomal abnormalities in men with severe male factor infertility. This is, therefore, the baseline rate that could be expected for sex chromosomal abnormalities in the offspring produced by ICSI. However, it appears that the actual rate is lower, based on a large prospective study performed by Bonduelle et al, 1996. This group in Belgium studied 904 pregnancies obtained after ICSI with chromosomal analysis in about two-thirds of the children. The incidence of sex chromosomal abnormalities was 1% or about one-quarter of what would be anticipated based on the previous study of the incidence of sex chromosomal abnormalities in the fathers. It is possible that embryos with a sex chromosomal abnormality may not survive as well as normal embryos and this may account for the much lower incidence seen in this prospective study.

 

Implications of Sex Chromosome Abnormalities

Major abnormalities of the cardiovascular system and the kidneys can occur in individuals with Turner's Syndrome (females missing one X chromosome), but are not seen in Klinefelter (XXY), the triple X, and the XYY syndromes. Importantly, mental retardation does not occur more often in individuals with sex chromosomal abnormalities than in normal controls. However, there is some evidence that academic achievement may be somewhat reduced compared with peers. Meshede and Horst (1997) concluded that the long term developmental prognosis is fairly good for individuals carrying a sex chromosomal abnormality and, if such an abnormality is diagnosed by amniocentesis following an ICSI pregnancy, a detailed discussion with a geneticist is warranted. The option of continuing such a pregnancy should be considered seriously.

 

Y Chromosome Microdeletions

Recent studies by Roberts and his colleagues from Minnesota (Pryor et al, 1997), studying a large group of men with severe male factor infertility, have demonstrated that about 10% of these men are missing one or more genes on the Y chromosome which are responsible for normal sperm production. These genes appear to be related only to sperm production and not to any other physical or mental characteristic. In other words, these men are entirely normal but have infertility because of severely reduced sperm counts. These abnormalities are called Y chromosome microdeletions, since they involve a very small area of the Y chromosome, and cannot be determined by the usual method of chromosomal analysis (karyotype). Therefore, at the present time, apart from DNA sequencing to look for these gene defects, there is no routine test available to detect these abnormalities. Gene sequencing is available at a few centers in Canada and in the United States but is not covered by medical health plans. In most cases, men who harbor a Y chromosome microdeletion will pass on this deletion to their male offspring through ICSI. As a result, the male offspring of these men should be normal with the exception of having low sperm counts and infertility similar to their fathers.

 

Major Congenital Abnormalities

A number of studies have compared ICSI pregnancies with in vitro fertilization pregnancies to determine if there is an increased risk of congenital abnormalities in the ICSI group. One of the first studies was done by Bonduelle et al (1995) in Belgium where 130 ICSI pregnancies were compared with 130 IVF pregnancies, in which the mothers were matched for age at the time of conception. Pregnancies were also matched for multiple pregnancy. These authors found that there was no difference in birth weights, lengths, or head circumference in the ICSI babies versus the IVF babies. They observed four major malformations in the ICSI group and six major malformations the IVF group. They concluded that there was no difference in the pediatric follow up of children born after ICSI compared with conventional IVF in age matched patients. In addition, the major malformation rate in both groups was within the normal range for the general population.

A follow up prospective study of 904 pregnancies obtained after ICSI by the same group was published in 1996 (Bonduelle et al). This study revealed a major malformation rate of 2.6%, which again is consistent with the major malformation rate seen in the general population.

A more recent study by Bowen et al (1998) from Australia compared children born by ICSI with those born after IVF or conceived naturally, and found no difference in major malformations between the three groups. All these studies are reassuring that ICSI does not increase the congenital malformation rate in offspring produced by this technique.

 

Chromosomal Analysis in Couples Undergoing ICSI

Two studies have examined the chromosomal make-up of both the male and female partner of couples referred for ICSI. One study from Holland by Van der Ven (1998) obtained karyotypes on both partners of 305 couples referred to the ICSI program. Ten of the men (3.3%) were found to have a chromosomal abnormality, which is in keeping with the previous finding by Tuerlings et al (1998) of a 4% incidence of chromosomal aberration in men with severe male factor infertility. A surprising finding, however, was that there was also a 3.3% incidence of abnormal karyotypes in the female partners who were thought to be normal at the time of referral. A second study by Mau et al (1997) looked at karyotypes in 150 couples referred for ICSI and found again that about 2% of the women had a chromosomal abnormality. The conclusion from these two studies is that karyotyping should be done on both partners prior to proceeding through the ICSI procedure, since a hidden female chromosomal factor may be present in some cases of suspected severe male factor infertility. The female chromosomal abnormality could also be transmitted to the offspring.

 

Developmental Outcome

Because of the short time most clinics have been performing ICSI, very limited information is available regarding motor or mental development in children conceived by this procedure. However, one study by Bowen et al (1998) compared a small number of children conceived by ICSI with children conceived by routine IVF and those conceived naturally. The study measured the Bayley mental development index (MDI) which has a mean of 100 and a normal range of 85-114 in the general population. Those children born as a result of ICSI had a mean MDI of 96 while those conceived by IVF or by natural conception had a mean of 102. When the data was further subdivided, there was no difference in the female babies born by the three methods, whereas boys born by ICSI had a significantly lower MDI compared to the other two groups. The authors concluded that most children conceived by ICSI are healthy and develop normally but there may be an increased risk of mild delays in development at one year. There was no increased incidence of mental retardation. However, since testing was performed at one year of age, precise assessment of mental development is difficult. In addition, karyotypes were not done on these children so it is unknown whether there was an increased incidence of sex chromosomal abnormalities in the males, which is known to lead to some developmental delay. There is a need for ongoing developmental follow up to see if increased risk of learning difficulties or intellectual impairment occurs at school age in these ICSI children.

 

Mechanical Damage to the Eggs from the Injection

Apart from gross oocyte damage rates, which are detectable immediately following ICSI, there are no data at present regarding potential damage to the chromosomes of the oocyte from insertion of the sperm injection needle. There is some concern that rough handling of the oocytes during cumulus cell stripping may displace the internal apparatus for chromosomal division (meiotic spindle) from its normal position near the polar body, so that the spindle could be damaged by injection of the sperm (Hewitson et al, 1999). However, no studies have been done to determine whether this hypothetical concern is realistic or not.

 

Conclusion

It would appear that men with severe male factor infertility have an increased incidence of chromosomal abnormalities, most likely sex chromosome abnormalities and Y chromosome microdeletions, which could be transmitted to the offspring by the ICSI procedure. However, it appears ICSI is remarkably safe despite these potential risks. The incidence of sex chromosomal abnormalities in ICSI offspring is likely in the range of 1%, while the percent of offspring with Y-chromosomal microdeletions is unknown at present in the absence of a routine test for this abnormality. Y-chromosome microdeletions, however, do not appear to cause any physical or mental abnormalities, and are related only to low sperm counts. The present review of the literature results in four recommendations regarding ICSI:

  1. ICSI should not replace routine IVF. IVF should be standard treatment if it is anticipated that the sperm can fertilize the eggs spontaneously.
  2. Chromosomal analysis or karyotyping should be done on both partners of couples referred for the ICSI procedure, and karyotyping should be done prior to the couple going through an ICSI cycle.
  3. The presence of cystic fibrosis gene mutations should be tested in both partners of couples in whom the male has congenital absence of the vas deferens or unexplained severe low sperm counts.
  4. Testing for Y-chromosome microdeletions should be offered to men with unexplained very low sperm counts.

References

Tuerlings et al, Eur J Hum Genet 6:194-200, 1998
Bonduelle et al, Hum Reprod 10:3327-31, 1995
Bonduelle et al, Hum Reprod 11(suppl 4):131-55, 1996
Meshede and Horst, Hum Reprod 12:1125-7, 1997
Bowen et al, Lancet 351:1529-34, 1998
Van der Ven et al, Hum Reprod 13:48-54, 1998
Mau et al (1997)
Hewitson et al, Nat Med 5:431, 1999



Andrology Laboratory  |  Intrauterine Insemination  |  In Vitro Fertilization (IVF)
Intracytoplasmic Sperm Injection (ICSI)  |  ICSI (Is It Safe?)  |  Oocyte Freezing
Epididymal Sperm Aspiration  |  Known Ovum Donor  |  Gestational Carrier
Embryo Cryopreservation  |  Therapeutic Donor Insemination (TDI)


back to the top
 
 
 


 
intracytoplasmic sperm injection
>> ICSI: Is It Safe?

 
infertility
  copyright tcart disclaimer Powered by: webxoom.com